1,081
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Hearing loss in outbred Hartley guinea pigs experimentally infected with Pichinde virus as a surrogate model of human mammarenaviral hemorrhagic fevers

, , , , , & show all
Pages 1049-1061 | Received 13 Mar 2022, Accepted 05 Jun 2022, Published online: 26 Jun 2022

References

  • Günther S, Lenz O. Lassa Virus. Crit Rev Clin Lab Sci. 2004;41:339–390.
  • Efficacy trials of Lassa Therapeutics: endpoints, trial design, site selection [Internet]. Paris, France: WHO Workshop; 2018 [cited 2021 Nov 17]. Available from: https://www.who.int/blueprint/what/norms-standards/LassaTxeval_FinalmeetingReport.pdf?ua=1
  • Richmond JK, Baglole DJ. Lassa fever: epidemiology, clinical features, and social consequences. BMJ. 2003;327: 1271–1275. (Clinical research ed).
  • McCormick JB. Encyclopedia of Virology. 3rd ed. Academic Press; 2008.
  • Prioritizing diseases for research and development in emergency contexts.
  • Murphy HL, Ly H. Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments. Virulence [Internet]. 2021;12(1):2989–3014. DOI:10.1080/21505594.2021.2000290
  • Brisse ME, Ly H. Hemorrhagic fever-causing arenaviruses: lethal pathogens and potent immune suppressors. Front Immunol. 2019;10:372.
  • Mateer EJ, Huang C, Shehu NY, et al. Lassa fever–induced sensorineural hearing loss: a neglected public health and social burden. PLoS Negl Trop Dis. 2018;12:e0006187.
  • Park AH, Gifford T, Schleiss MR, et al. Development of cytomegalovirus-mediated sensorineural hearing loss in a guinea pig model. Arch Otolaryngology head and Neck Surg. 2010;136:48.
  • Wang Y, Patel R, Ren C, et al. A comparison of different murine models for cytomegalovirus-induced sensorineural hearing loss. Laryngoscope. 2013;123:2801–2806.
  • Korver AMH, Smith RJH, Camp GV, et al. Congenital hearing loss. Nat Rev Dis Primers. 2017;3:16094.
  • Hashimoto H, Fujioka M, Kinumaki H, Kinki Ambulatory Pediatrics Study Group. An office-based prospective study of deafness in mumps. Pediatr Infect Dis J. 2009;28:173–175.
  • Ficenec SC, Schieffelin JS, Emmett SD. A review of hearing loss associated with zika, ebola, and lassa fever. Am J Trop Med Hyg. 2019; 101(3):484–490.
  • Herrmann M, Xu P, Liu A. Rapid ascending sensorimotor paralysis, hearing loss, and fatal arrhythmia in a multimorbid patient due to an accidental overdose of fluoxetine. Case Rep Neurol Med. 2017;2017:5415243.
  • Shaw KA, Babu KM, Hack JB. Methadone, another cause of opioid-associated hearing loss: a case report. J Emerg Med. 2011;41:635–639.
  • Nair EL, Cienkowski KM, Michaelides E. The impact of sudden hearing loss secondary to heroin overdose on fitting outcomes. Am J Audiol. 2010;19:86.
  • Schweitzer VG, Darrat I, Stach BA, et al. Sudden bilateral sensorineural hearing loss following polysubstance narcotic overdose. J Am Acad Audiol. 2011;22:208–214.
  • Harris JP, Sharp PA. Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope. 1990;100:516?524.
  • Lin C, Lin S-W, Weng S-F, et al. Risk of sudden sensorineural hearing loss in patients with systemic lupus erythematosus: a population-based cohort study. Audiology Neuro-Otology. 2013;18:95–100.
  • Ibekwe TS, Okokhere PO, Asogun D, et al. Early-onset sensorineural hearing loss in Lassa fever. Eur Arch Oto-Rhino-Laryngology. 2011;268:197–201.
  • Okokhere PO, Ibekwe TS, Akpede GO. Sensorineural hearing loss in Lassa fever: two case reports. J Med Case Rep. 2009;3:36.
  • Ficenec SC, Percak J, Arguello S, et al. Lassa fever induced hearing loss: the neglected disability of hemorrhagic fever. Int. J Infect Dis [Internet]. 2020; Available from: https://pubmed.ncbi.nlm.nih.gov/32795603/
  • Christiansen JB. Sociological implications of hearing loss. Ann N Y Acad Sci. 1991;630:230–235.
  • Sattler RA, Paessler S, Ly H, et al. Animal models of lassa fever. Pathogens. 2020;9:197.
  • Yun NE, Ronca S, Tamura A, et al. Animal model of sensorineural hearing loss associated with lassa virus infection. J Virol. 2015;90:2920–2927.
  • Cashman KA, Wilkinson ER, Zeng X, et al. Immune-mediated systemic vasculitis as the proposed cause of sudden-onset sensorineural hearing loss following lassa virus exposure in cynomolgus macaques. Mbio. 2018;9: e01896–18.
  • Huynh T, Gary JM, Welch SR, et al. Lassa virus antigen distribution and inflammation in the ear of infected strain 13/N guinea pigs. Antiviral Res. 2020;183:104928.
  • Lan S, Shieh W-J, Huang Q, et al. Virulent infection of outbred Hartley guinea pigs with recombinant Pichinde virus as a surrogate small animal model for human Lassa fever. Virulence [Internet]. 2020; DOI: 10.1080/21505594.2020.1809328
  • Jahrling PB, Hesse RA, Rhoderick JB, et al. Pathogenesis of a pichinde virus strain adapted to produce lethal infections in guinea pigs. Infect Immun. 1981;32:872–880.
  • Connolly BM, Jenson AB, Peters CJ, et al. Pathogenesis of Pichinde virus infection in Strain 13 guinea pigs: an immunocytochemical, virologic, and clinical chemistry study. Am J Trop Med Hyg. 1993;49:10–24.
  • Lan S, McLay Schelde L, Wang J, et al. Development of infectious clones for virulent and avirulent Pichinde viruses: a model virus to study arenavirus-induced hemorrhagic fevers. J Virol. 2009;83:6357–6362.
  • Lan S, McLay L, Aronson J, et al. Genome comparison of virulent and avirulent strains of the arenavirus Pichinde. Arch Virol. 2008;153:1241.
  • Huang Q, Shao J, Lan S, et al. In vitro and in vivo characterizations of Pichinde viral nucleoprotein exoribonuclease functions. J Virol. 2015;89:6595–6607.
  • Liang Y, Lan S, Ly H. Molecular determinants of Pichinde virus infection of guinea pigs–a small animal model system for arenaviral hemorrhagic fevers. Ann N Y Acad Sci. 2009;1171. Suppl:E6574. Suppl:E6574.
  • Coleman B, Hardie N, de Silva M, et al. A protocol for cryoembedding the adult guinea pig cochlea for fluorescence immunohistology. J Neurosci Methods. 2009;176:144–151.
  • Dhanwani R, Ly H, Liang Y. Recombinant tri-segmented Pichinde virus as a novel live viral vaccine platform. Methods Mol Biol. Vol. 1581. Clifton, NJ; 2017. p. 169–179.
  • Marriott K. Comparative pathogenesis of passaged Pichinde virus variants in outbred guinea pigs. FASEB J. 1997;11:669.
  • Zhang L, Marriott KA, Harnish DG, et al. Reassortant analysis of guinea pig virulence of pichinde virus variants. Virology. 2001;290:30–38.
  • Cohen BE, Durstenfeld A, Roehm PC. Viral causes of hearing loss: a review for hearing health professionals. Trends Hear. 2014;18:2331216514541361.
  • Chen X, Fu Y, Zhang T. Role of viral infection in sudden hearing loss. J Int Med Res. 2019;47:2865–2872.
  • Kainulainen MH, Spengler JR, Welch SR, et al. Protection from lethal Lassa disease can be achieved both before and after virus exposure by administration of single-cycle replicating Lassa virus replicon particles. J Infect Dis [Internet]. 2019;220(8): 1281–1289. DOI: 10.1093/infdis/jiz284/5510080.
  • Spandow O, Anniko M, Moller A. The round window as access route for agents injurious to the inner ear. Am J Otolaryngol. 1988;9:327–335.
  • Caye-Thomasen P, Worsoe L, Brandt CT, et al. Routes, dynamics, and correlates of cochlear inflammation in terminal and recovering experimental meningitis. Laryngoscope. 2009;119:1560–1570.
  • Nakashima T, Naganawa S, Sone M, et al. Disorders of cochlear blood flow. Brain Res Rev. 2003;43:17–28.
  • Jenkins H, Pollak A, Fisch U. Polyarteritis nodosa as a cause of sudden deafness. A human temporal bone study. Am J Otolaryngol. 1981;2:99–107.
  • Gussen P. Polyarteritis nodosa and deafness. A human temporal bone study. Arch Otolaryngology–head & Neck Surgery. 1977;217:263–271.
  • Joglekar S, Deroee AF, Morita N, et al. Polyarteritis nodosa: a human temporal bone study. Am J Otolaryngol. 2010;31:221–225.
  • Wolf M, Kronenberg J, Engelberg S, et al. Rapidly progressive hearing loss as a symptom of polyarteritis nodosa. Am J Otolaryngol. 1987;8:105–108.
  • Dorado JCA, Fernandez MDPB, Villarin SR, et al. Audiovestibular manifestations in systemic vasculitis. Acta Otorrinolaringol Esp. 2009;60:432–442.
  • Berrettini S, Ferri C, Ravecca F, et al. Progressive sensorineural hearing impairment in systemic vasculitides. Sem Arth Rheumatology. 1998;27:301–318.
  • Rahne T, Plontke S, Keyber G. Vasculitis and the ear: a literature review. Curr Opin Rheumatol. 2020;32:47–52.
  • Yun NE, Seregin AV, Walker DH, et al. Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus. J Virol. 2013;87:10908–10911.
  • Port JR, Wozniak DM, Oestereich L, et al. Severe human Lassa fever is characterized by non-specific T-cell activation and lymphocyte homing to inflamed tissues. J Virology [Internet]. 2020. Available from: http://jvi.asm.org/
  • Flatz L, Rieger T, Mekler D, et al. T cell-dependence of lassa fever pathogenesis. PLoS Pathog. 2010;6:e1000836.
  • Schraff SA, Schleiss MR, Brown DK, et al. Macrophage inflammatory proteins in cytomegalovirus-related inner ear injury. Otolaryngology-Head and Neck Surgery. 2007;137:612–618.
  • Schachtele SJ, Mutnal MB, Schleiss MR, et al. Cytomegalovirus-induced sensorineural hearing loss with persistent cochlear inflammation in neonatal mice. J Neurovirol. 2011;17:201–211.
  • White DR, Choo DI, Stroup G, et al. The effect of cidofovir on cytomegalovirus-induced hearing loss in a guinea pig model. Arch Otolaryngology–head & Neck Surgery. 2006;132:608.
  • Tondury G, Smith DW. Fetal rubella pathology. J Paediatr. 1966;68:867–879.
  • Webster WW. Teratogen update: Congenital rubella. Teratology. 58:13–23.
  • Sindura KP, Banerjee M. An immunological perspective to non-syndromic sensorineural hearing loss. Front Immunology [Internet]. 2019;10:2848. Available from: https://www.frontiersin.org/article/10.3389/fimmu.2019.02848/full
  • Rechavi E, Somech R. Maturation of the immune system in the fetus and the implications for congenital CMV. Best practice and research. Clin Obstetrics Gynaecol. 2019;60:35–41.